Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, and effects of MK-0974 (Telcagepant) on exercise tolerance in stable angina patients completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Heart Disease

Drugs mentioned

• Telcagepant (telcagepant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Angina Pectoris, Coronary Heart Disease | Phase 1 | Status: COMPLETED | Results posted: 2014-09-10